Search Results - "Bazoge, Maëva"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    S1289 Clinical Validation of a Novel Software Tool to Guide the Intravenous-to-Subcutaneous Switching of Infliximab in Patients With Inflammatory Bowel Diseases

    S1289 Clinical Validation of a Novel Software Tool to Guide the Intravenous-to-Subcutaneous Switching of Infliximab in Patients With Inflammatory Bowel Diseases by Hoffert, Yannick, Wang, Zhigang, Fumery, Mathurin, Nachury, Maria, Bazoge, Maeva, Buisson, Anthony, Dreesen, Erwin

    Published in The American journal of gastroenterology (01-10-2024)
    “…Introduction:Therapeutic drug monitoring (TDM) of intravenous (IV) infliximab is increasingly practiced to improve therapeutic outcomes in patients with…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Development and Validation of a Score to Assess Transmural Healing and Response in Patients With Crohn’s Disease

    Development and Validation of a Score to Assess Transmural Healing and Response in Patients With Crohn’s Disease by Buisson, Anthony, Junda, Jérémy, Vignette, Jeanne, Lecoq, Emma, Bouguen, Guillaume, Goutorbe, Felix, Scanzi, Julien, Coban, Dilek, Dodel, Marie, Bazoge, Maëva, Pereira, Bruno, Hordonneau, Constance

    Published in Clinical gastroenterology and hepatology (01-11-2024)
    “…Because transmural healing (TH) could be the best therapeutic target in Crohn’s disease (CD), we aimed to build and validate a score to assess TH and…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Tu1840 CDST (CLINICAL DECISION SUPPORT TOOL) IS PREDICTIVE OF STEROID-FREE CLINICAL REMISSION IN PATIENTS WITH CROHN'S DISEASE TREATED WITH VEDOLIZUMAB IN A SPECIFIC MANNER WHICH IS MAINLY DRIVEN BY THE SERUM LEVEL OF ALBUMIN

    Tu1840 CDST (CLINICAL DECISION SUPPORT TOOL) IS PREDICTIVE OF STEROID-FREE CLINICAL REMISSION IN PATIENTS WITH CROHN'S DISEASE TREATED WITH VEDOLIZUMAB IN A SPECIFIC MANNER WHICH IS MAINLY DRIVEN BY THE SERUM LEVEL OF ALBUMIN by Buisson, Anthony, Nancey, Stephane, Dodel, Marie, Gay, Claire, Coban, Dilek, Bazoge, Maëva, Pereira, Bruno, Boschetti, Gilles

    Published in Gastroenterology (New York, N.Y. 1943) (18-05-2024)
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Sa1770 PREVALENCE, CAUSES AND IMPACT OF BOWEL URGENCY ON PATIENTS’ QUALITY OF LIFE AND DISABILITY IN ULCERATIVE COLITIS: RESULTS FROM THE B-UNIC COHORT

    Sa1770 PREVALENCE, CAUSES AND IMPACT OF BOWEL URGENCY ON PATIENTS’ QUALITY OF LIFE AND DISABILITY IN ULCERATIVE COLITIS: RESULTS FROM THE B-UNIC COHORT by Buisson, Anthony, Baraduc, Emma, Dodel, Marie, Coban, Dilek, Bazoge, Maëva, Pereira, Bruno

    Published in Gastroenterology (New York, N.Y. 1943) (18-05-2024)
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Early Biological Therapy Within 12 Months of Diagnosis Leads to Higher Transmural Healing Rates in Crohn’s Disease

    Early Biological Therapy Within 12 Months of Diagnosis Leads to Higher Transmural Healing Rates in Crohn’s Disease by Revés, Joana, Fernandez-Clotet, Agnes, Ordás, Ingrid, Buisson, Anthony, Bazoge, Maëva, Hordonneau, Constance, Ellul, Pierre, D’Anastasi, Melvin, Elorza, Ainara, Aduna, Marta, Rodríguez-Lago, Iago, Lajas, Inês Sousa, Raimundo, Ana, Bettencourt, Paulo J.G., Freire, Gonçalo, Sousa, Pedro, Primitivo, Ana, Delgado, Ivo, Rimola, Jordi, Torres, Joana

    Published in Clinical gastroenterology and hepatology (30-08-2024)
    “…Transmural healing (TH) is emerging as a potential Crohn's disease (CD) treatment target. Early biological treatment seems to be associated with improved…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: